Biotron: Half Yearly Report and Accounts
Filed with ASX · · 24 pages · English
Story so far
Earlier from Biotron
- Successful Issue of the Entitlement Offer Shortfall
- Quarterly Activities/Appendix 4C Cash Flow Report
- Security Class Reinstatement to Quotation - BITO
- Rights Issue Close
- Security Class Suspension from Quotation - BITO
Later from Biotron
- Hepatitis B Virus Program Update
- $525K R&D Rebate Received
- Sedarex First Milestone Met
- Resignation of Managing Director and Appendix 3Z
- Appointment of CEO and Executive Director
Follow Biotron into a list and get an email when it puts out news.
Follow Biotron